Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Series A
Series B
Focus Areas
BioTech
Manufacturing
Pharmaceuticals
About Investor
James W. Brush is General Partner and Portfolio Manager at Frazier Healthcare Partners, where he oversees $100 K–$5 M Series A and B investments in biotech, pharmaceuticals and manufacturing ventures. He joined Frazier in 2009 and leverages over 30 years of drug-discovery and development leadership—most recently as Senior Vice President of Worldwide Discovery Research at Pfizer—to source and advise on new life-sciences opportunities.
Previous investments
Maze Therapeutics
120M |2024
Amunix
120M |2021
73M |2020
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP